Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.27) per share for the quarter.
Sensei Biotherapeutics Trading Down 1.2 %
Shares of SNSE opened at $0.47 on Wednesday. The stock’s 50 day moving average is $0.49 and its two-hundred day moving average is $0.52. The firm has a market cap of $11.83 million, a P/E ratio of -0.40 and a beta of 0.17. Sensei Biotherapeutics has a 12 month low of $0.38 and a 12 month high of $1.94.
Analysts Set New Price Targets
Separately, HC Wainwright reissued a “buy” rating and set a $4.00 target price on shares of Sensei Biotherapeutics in a research note on Wednesday, January 8th.
About Sensei Biotherapeutics
Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.
Read More
- Five stocks we like better than Sensei Biotherapeutics
- What Are Dividend Champions? How to Invest in the Champions
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What is the Australian Securities Exchange (ASX)
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Sensei Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensei Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
